Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/kr8y-gn58

technical paper

ENDO 2021

March 21, 2021

Live on Underline

Canine Pituitary Organoids as 3D in vitro model for Cushing Disease

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2021

Antisense Oligonucleotides as a Novel Therapy for Cushing's Disease
technical paper

Antisense Oligonucleotides as a Novel Therapy for Cushing's Disease

ENDO 2021

21 March 2021

Similar lecture

Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)
technical paper

Efficacy and Safety of Higher Dulaglutide Doses (3.0 MG and 4.5 MG) When Added to Metformin in Patients With Type 2 Diabetes: A Phase 3, Randomized, Double-Blind, Parallel ARM Study (Award-11)

ENDO 2020

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved